|Mr. Paul Peros||Exec. Chairman & CEO||903.46k||N/A||N/A|
|Mr. Jeffrey David Edwards||Founder, MD, Technical Director & Exec. Director||235.05k||N/A||N/A|
|Mr. Sergej Dolezil||Chief Financial Officer||N/A||N/A||N/A|
|Dr. Matthew McIldowie||Chief Scientific Officer||N/A||N/A||N/A|
|Mr. Henko Vos C.A.||Company Sec.||N/A||N/A||N/A|
|Dr. Michael Roberts||Scientific Adviser||N/A||N/A||N/A|
Wellfully Limited, together with its subsidiaries, develops dermaportation and enhanced transdermal polymer technologies for use in the pharmaceutical, cosmetic and skincare, and consumer healthcare sectors in Singapore and Europe. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. It develops magnetic micro-array and powerless drug delivery technologies; and designs and develops drug patches, applicators, and brushes products. The company was formerly known as OBJ Limited and changed its name to Wellfully Limited in September 2020. Wellfully Limited was incorporated in 1992 and is based in Leederville, Australia.
Wellfully Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.